Novo Nordisk Plans To Catch Them Young; Kicks Off DAWN Youth Program For Young Diabetics in India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Spurred by an alarming rise in the number of diabetic patients in India, Danish anti-diabetes drug maker Novo Nordisk has launched its international DAWN Youth program in the country to explore the attitudes, wishes and needs of young people with or at risk of diabetes along with their families. DAWN stands for Diabetes Attitudes Wishes and Needs and is operational in more than 30 countries